S-588410
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-588410, covering 2017-12-21 to 2017-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer [Phase 2]